Clinical review 31: Anabolic-androgenic steroids and athletes: what are the issues?
Rogol
A D
AD
Department of Pediatrics, University of Virginia, Charlottesville 22908.
Yesalis
C E
CE
D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000728:Androgens / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009132:Muscles / Q000502:physiology; D013177:Sports; D019966:Substance-Related Disorders; D013739:Testosterone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
D045930:Anabolic Agents; D000728:Androgens; D013739:Testosterone